Martin Shkreli on Getting Arrested & Charged with Ponzi Scheme, Paying $5M Bond (Part 10)

Watch the full interview now as a VladTV Youtube Member – https://www.youtube.com/vladtv/join

Part 11: https://youtu.be/OtXUae0h6C0
Part 9: https://youtu.be/blFDTVmFraQ
Part 1: https://youtu.be/pun5ZxRHa9U
——–
Martin Shkreli shared details about his arrest, legal battles, and controversial business practices. Shkreli, infamous for drastically hiking drug prices, faced a $65 million lawsuit alleging breaches including stock trading irregularities. According to Shkreli, despite accusations, he was later awarded $9 million.

Shkreli discussed the process leading to his arrest for securities fraud and subsequent $5 million bail. He criticized the legal system, alleging that corporate influence and a revolving door between big law firms and prosecutorial offices led to his indictment. Shkreli dismissed claims that he operated his company like a Ponzi scheme, despite the U.S. Attorney’s Robert assertions.

Shortly before his arrest, Shkreli led an investor group to acquire KaloBios Pharmaceuticals, but he was dismissed as CEO following his indictment. He claimed the ensuing government actions caused more financial turmoil than his own, maintaining his innocence on the charges he was convicted of while expressing pride in beating several others.

The videos on this website are sourced from YouTube, and are embedded using the public API provided by YouTube. By using this website, you acknowledge that the videos displayed are the property of their respective owners, and remain subject to the copyright laws of the owner. All articles, images, product names, logos, and brands featured on this website are the property of their respective owners, and we make no claim to ownership or affiliation with any of these entities. Please note that your use of embedded videos from YouTube is subject to YouTube's terms of service and privacy policy. By using this website and viewing embedded videos, you agree to abide by YouTube's terms of service and privacy policy. If you have any questions or concerns about the content displayed on this website, please contact us using the information provided on the website.